Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma
详细信息 查看全文
- 作者：Sheng-yu Wang (1)
Xin-ping Kuai (1)
Xiao-xi Meng (2)
Ning-yang Jia (3)
Hui Dong (4) - 关键词：Liver neoplasm ; Angiomyolipoma ; Hepatocellular carcinoma ; Fat ; Magnetic resonance imaging
- 刊名：Abdominal Imaging
- 出版年：2014
- 出版时间：April 2014
- 年：2014
- 卷：39
- 期：2
- 页码：323-333
- 全文大小：1,568 KB
- 参考文献：1. Ishak KG (1976) Mesenchymal tumors of the liver. In: Okuda K, Peters RL (eds) / Hepatocellular carcinoma. New York: Wiley, pp 247-07
2. Prasad SR, Wang H, Rosas H, et al. (2005) Fat-containing lesions of the liver: radiologic–pathologic correlation. Radiographics 25:321-31 CrossRef
3. Basaran C, Karcaaltincaba M, Akata D, et al. (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103-110 CrossRef
4. Yan F, Zeng M, Zhou K, et al. (2002) Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol 41:12-8 CrossRef
5. Jeon TY, Kim SH, Lim HK, Lee WJ (2010) Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver. Eur J Radiol 73:601-06 CrossRef
6. Chung AY, Ng SB, Thng CH, Chow PK, Ooi LP (2002) Hepatic angiomyolipoma mimicking hepatocellular carcinoma. Asian J Surg. 25:251-54 CrossRef
7. Cai PQ, Wu YP, Xie CM, et al. (2013) Hepatic angiomyolipoma: CT and MRI imaging findings with clinical–pathologic comparison. Abdom Imaging 38:482-89 CrossRef
8. Ahmadi T, Itai Y, Takahashi M, et al. (1998) Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging 23:520-26 CrossRef
9. Ji JS, Lu CY, Wang ZF, et al. (2013) Epithelioid angiomyolipoma of the liver: CT and MRI features. Abdom Imaging 38:309-14 CrossRef
10. Martin J, Puig J, Falco J, et al. (1998) Hyperechoic liver nodules: characterization with proton fat–water chemical shift MR imaging. Radiology 207:325-30
11. Pupulim LF, Hakimé A, Barrau V, et al. (2009) Fatty?hepatocellular carcinoma: radiofrequency ablation: imaging findings. Radiology 250:940-48 CrossRef
12. Bieze M, van den Esschert JW, Nio CY, et al. (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR 199:26-4 CrossRef
13. Itai Y, Ohtomo K, Kokubo T, et al. (1986) CT of hepatic masses: significance of prolonged and delayed enhancement. AJR 146:729-33 CrossRef
14. Kim SH, Lim HK, Lee WJ, Choi D, Park CK (2009) Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. Eur J Radiol 69:123-30 CrossRef
15. Hooper LD, Mergo PJ, Ros PR (1994) Multiple hepatorenal angiomyolipmas: diagnosis with fat suppression, gadolinium-enhanced MRI. Abdom Imaging 19:549-51 CrossRef
16. Christopher DM, Fletcher K, Krishnan U, Fredrik E (2002) Pathology and genetics of tumors of soft tissue and bone, vol 222. IARC Press, Lyon
17. Chang Z, Zhang JM, Ying JQ, GE YP (2011) Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions. J Gastrointest Liver Dis 20:65-9
18. Nonomura A, Mizukami T, Kadoya M (1994) Angiomyolipoma of the liver: a collective review. J Gastroenterol 29:95-05 CrossRef
19. Tsui WM, Colombari R, Portmann BC, et al. (1999) Hepatic angiomyolipma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol 23:34-8 CrossRef
20. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282-89 CrossRef
21. Yoshikawa J, Matsui O, Takashima T, et al. (1988) Fatty metamorphosis in hepatocellular carcinoma: radiologic features in 10 cases. AJR 151:717-20 CrossRef
22. Ayyappan AP, Jhaveri KS (2010) CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther 10:507-19 CrossRef
23. Kim SH, Lim HK, Lee WJ, Choi D, Park CK (2009) Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. Eur J Radiol 69:123-30 CrossRef
24. Winter TC 3rd, Takayasu K, Muramatsu Y, et al. (1994) Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 192:379-87
25. Anysz-Grodzicka A, Pacho R, Grodzicki M, et al. (2013) Angiomyolipoma of the liver: analysis of typical features and pitfalls based on own experience and literature. Clin Imaging 37:320-26 CrossRef
26. Hussain SM, Zondervan PE, Izermans JN, et al. (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023-036 CrossRef
27. Balci NC, Befeler AS, Bieneman BK, et al. (2009) Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging. Acad Radiol 16:963-68 CrossRef
28. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47-6 CrossRef
29. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. (2006) ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 187:1521-530 CrossRef
30. Taouli B, Thakur R, Mannelli L, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251:398-07 CrossRef - 作者单位：Sheng-yu Wang (1)
Xin-ping Kuai (1)
Xiao-xi Meng (2)
Ning-yang Jia (3)
Hui Dong (4)
1. Department of Radiology, Changshu Second People’s Hospital, Changshu, Jiangsu, 215500, China
2. Department of Radiology, Changzheng Hospital, The Second Military Medical University, Shanghai, 200003, China
3. Department of Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, 200438, China
4. Department of Pathology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, 200438, China - ISSN：1432-0509
文摘
Objective The purpose of this study was to evaluate MRI features for the differentiation of hepatic angiomyolipoma (HAML) from fat-containing hepatocellular carcinoma. Methods We retrospectively reviewed the MRI findings of 20 patients with 22 hepatic angiomyolipomas and 25 patients with fat-containing hepatocellular carcinomas before surgery. The MRI features and apparent diffusion coefficient (ADC) for the two types of tumors were compared and analyzed. Results Fat was not detected in nine (40.9%) of the angiomyolipomas. An enhancement pattern of the washout area was seen in eight (36.4%) of the angiomyolipomas and 21 of the hepatocellular carcinomas (84%) (p?=?0.001). The sensitivity, specificity, and accuracy of the enhancement pattern for HAML were 63.6% (14/22), 84% (21/25), and 74.5% (35/47), respectively. An early draining vein was seen in 16 (72.7%) angiomyolipomas and two hepatocellular carcinomas (8%) (p?<?0.001). The sensitivity, specificity, and accuracy of an early draining vein for detecting HAML was 72.7% (16/22), 92% (23/25), and 83.0% (39/47), respectively. Tumor vessels were noted in 18 (81.8%) angiomyolipomas and six hepatocellular carcinomas (24%) (p?<?0.001). The sensitivity, specificity, and accuracy of tumor vessels for HAML were 81.8% (18/22), 76% (19/25), and 78.7% (37/47), respectively. Pseudocapsules were absent in 21 (95.5%) angiomyolipomas as compared with 3 (12%) hepatocellular carcinomas (p?<?0.001). The sensitivity, specificity, and accuracy of pseudocapsules for HAML were 95.5% (21/22), 88% (22/25), and 91.5% (43/47), respectively. The ADC of the angiomyolipomas (1.92?±?0.29?×?10??mm2/s) was significantly higher than that for hepatocellular carcinomas (1.33?±?0.25?×?10??mm2/s) (p?<?0.001). Conclusion The presence of an early draining vein and tumor vessels, the absence of pseudocapsules and a higher ADC in the hypervascular hepatic tumor on the MRI were helpful for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma.